1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment

Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment

  • December 2013
  • -
  • Industry Standard Research
  • -
  • 118 pages

ISR identifies and explores the patterns and preferences surrounding the needs, treatments, and side-effects of patients living with autoimmune diseases. This report offers pharmaceutical, biotech, and service provider companies with an opportunity to position their product, enhance clinical development, and improve clinical trial patient recruitment. The report provides value to both commercial and clinical development decision-makers.

What you will learn in this report:
- Prevalence of symptoms associated with each disease and the symptoms that cause the most difficulty
- Patient satisfaction with current abilities, the occurrence of pain, and how the disease affects everyday life
- How a patient’s socio-economic status and level of satisfaction with their condition/ treatment regimen affect their willingness to enroll in a clinical trial
- Trends in disease diagnosis
- Payment issues with insurance
- Patient interactions with physicians (PCPs andSpecialists) and the non-medical individuals they turn to the most for support
- And more…

How you can use this report:
- Design your marketing and advertising plans to account for the current issues and unmet patient needs
- Understand patient willingness and hesitations around enrolling in a clinical trial to position enrollment in a positive way
- Consider symptom relief, medication side effects, cost, and many other factors when planning for research and development

Table Of Contents

Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment
Table of Contents

Copyright and usage guidelines .4
Introduction .5
Methodology ..6
Data collection and screening criteria .6
Sample source and geography .7
Statistical significance ..7
Executive Summary ..9
Key findings for the pharmaceutical industry 13
Key findings for clinical development 14
Demographics ..17
Age ..17
Gender ..20
Race/ethnicity 22
Education level ..24
Family history of autoimmune disease .25
Household income ..26
Health insurance ..29
Unmet needs of autoimmune patients 32
Prevalence of symptoms among autoimmune patients ..33
Symptom that causes the most difficulty 40
Payment issues with insurance .45
What patients want the pharmaceutical company to recognize .48
Current abilities of respondents with an autoimmune disease ..50
General health status .51
Current state of autoimmune disease ..52
Satisfaction with current physical ability .54
Occurrence of autoimmune-related pain 57
Autoimmune disease effect on everyday life 60
Segment differences - your mood ..60
Segment differences - your ability to move around ..61
Segment differences - your ability to sleep 62
Segment differences - your normal work 64
Segment differences - your recreational activities .65
Segment differences - your enjoyment of life ..67
Trends in autoimmune diagnosis 69
Autoimmune disease diagnoses ..70
Time since original diagnosis .71
Amount of time between first symptoms and official diagnosis .73
Type of physician that made original diagnosis of disease .74
Percent of patients who sought second opinions 76
Incorrect diagnosis ..77
Patient care and physician interaction 78
Type of physician, care givers, experts currently being seen for treatment ………………………….79
Types of primary physicians autoimmune patients are seeing .81
Amount of personal research 84
Who people turn to for input on medical decisions (besides physicians) …………………………..86
Willingness to participate in a clinical trial related to autoimmune disease .90
Treatment and satisfaction 92
Treatment regimens ..93
Segment differences - Current treatment regimen ..94
Segment differences - Treatment regimen 12 months ago ..96
Other current treatments 98
Percent of patients who have stopped a treatment for their autoimmune disease .99
Reason for stopping a treatment regimen 100
Goal of current medication regimen ..102
Current regimen satisfaction ..106
Satisfaction with current regiment - by aspect .109
Segment differences - Ease of use ..109
Segment differences - Cost .110
Segment differences - Side effects ..111
Segment differences - Effectiveness ..112
Primary treatment aspect that patients want improved ..115
About Industry Standard Research .118

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Global Eye Disease Statistics

  • November 2016
    7 pages
  • Eye Disease  

  • World  

    Tanzania  

View report >

Infectious Disease Statistics in South Africa

  • November 2016
    9 pages
  • Infectious Dise...  

  • South Africa  

    Africa  

View report >

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.